106 related articles for article (PubMed ID: 3502523)
1. Differences of sensitivity to autologous cytotoxic lymphocytes between primary tumor and its cervical lymph node metastases.
Maehara T; Eura M; Ikawa T; Ishikawa T
Auris Nasus Larynx; 1987; 14(3):187-98. PubMed ID: 3502523
[TBL] [Abstract][Full Text] [Related]
2. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
[TBL] [Abstract][Full Text] [Related]
3. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
[TBL] [Abstract][Full Text] [Related]
4. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
[TBL] [Abstract][Full Text] [Related]
5. Generation of human cytotoxic T lymphocytes against autologous solid tumors by autologous mixed lymphocyte tumor cell culture with T cell growth factor.
Ichino Y; Ishikawa T
Auris Nasus Larynx; 1985; 12 Suppl 2():S226-33. PubMed ID: 2942136
[TBL] [Abstract][Full Text] [Related]
6. [Induction of cytotoxic activity from regional lymph node lymphocytes in head and neck malignant tumor].
Yoda J
Nihon Jibiinkoka Gakkai Kaiho; 1992 May; 95(5):748-58. PubMed ID: 1619515
[TBL] [Abstract][Full Text] [Related]
7. Immune response in cervical lymph nodes from patients with primary oral squamous cell carcinoma.
Gonçalves AS; Costa NL; Arantes DA; de Cássia Gonçalves Alencar R; Silva TA; Batista AC
J Oral Pathol Med; 2013 Aug; 42(7):535-40. PubMed ID: 23278174
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
[TBL] [Abstract][Full Text] [Related]
9. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.
Ichino Y; Ishikawa T
Gan; 1984 May; 75(5):436-41. PubMed ID: 6235143
[TBL] [Abstract][Full Text] [Related]
10. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
Morikawa Y; Watanabe S; Kodama T
Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
[TBL] [Abstract][Full Text] [Related]
11. Phorbol dibutyrate plus ionomycin improves the generation of cytotoxic T cells from draining lymph nodes of patients with advanced head and neck cancer.
McGrath PC; Hamby LS; Freeman JW
Am J Surg; 1992 Dec; 164(6):610-4. PubMed ID: 1463110
[TBL] [Abstract][Full Text] [Related]
12. Neck node immunoreactivity in head and neck carcinoma.
Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
[TBL] [Abstract][Full Text] [Related]
13. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
Watanabe Y; Hashizume Y; Shimizu J; Yoshida M; Watanabe S; Iwa T; Sakai S; Migita S; Sato H; Murayama T
Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
[TBL] [Abstract][Full Text] [Related]
14. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
15. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
Uchida A; Moore M; Klein E
Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
[TBL] [Abstract][Full Text] [Related]
16. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
[TBL] [Abstract][Full Text] [Related]
18. Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma.
Darrow TL; Slingluff CL; Seigler HF
Cancer; 1988 Jul; 62(1):84-91. PubMed ID: 3260124
[TBL] [Abstract][Full Text] [Related]
19. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
Wang MB; Lichtenstein A; Mickel RA
Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
[TBL] [Abstract][Full Text] [Related]
20. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells.
Sato T; Sato N; Takahashi S; Koshiba H; Kikuchi K
Cancer Res; 1986 Sep; 46(9):4384-9. PubMed ID: 3488124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]